← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Orpro Therapeutics, Inc.
San Diego, CA
$2,644,564
Total funding
4
Grants
Funding over time
peak $2M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,644,564 · 4
By mechanism
R44$1,724,117 · 1
R41$508,988 · 1
R43$411,459 · 2
Investigators at Orpro Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis$1,499,635
R44 · FY2018 · HL
Engineered Monothiol Thioredoxin for Treatment of Radiation Induced Lung Injury$508,988
R41 · FY2025 · HL
Mucoadhesive drug conjugates for controlled-release inhalation delivery$228,370
R43 · FY2018 · HL
Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis$224,482
R44 · FY2018 · HL
Development of human thioredoxin as a mucolytic therapy for Cystic Fibrosis$183,089
R43 · FY2012 · HL